Citation

Williamson DS, Smith GP, Acheson-Dossang P, Bedford ST, Chell V, Chen IJ, Daechsel JCA, Daniels Z, David L, Dokurno P, Hentzer M, Herzig MC, Hubbard RE, Moore JD, Murray JB, Newland S, Ray SC, Shaw T, Surgenor AE, Terry L, Thirstrup K, Wang Y, Christensen KV.: Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1). J Med Chem, Volume 60 (21), 2017

Authors

Acheson-Dossang P, Bedford ST, Chell V, Chen IJ, Christensen KV., Daechsel JCA, Daniels Z, David L, Dokurno P, Hentzer M, Herzig MC, Hubbard RE, Moore JD, Murray JB, Newland S, Ray SC, Shaw T, Smith GP, Surgenor AE, Terry L, Thirstrup K, Wang Y, Williamson DS

Journal

J Med Chem

Year

2017

DOI

10.1021/acs.jmedchem.7b01186

PubMed

29023112

Machine-readable

REST APIRDF